Bumper Offer - Urjas oil Just @ Rs. 1
Orcerin GM Tablet (15) is a prescription drug, available for use as Tablet. Other than this, Orcerin GM Tablet (15) has some other therapeutic uses, which have been discussed ahead.
The right dosage of Orcerin GM Tablet (15) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Orcerin GM Tablet (15) include Nausea or vomiting, Diarrhoea, Heartburn. While these are the most often observed Orcerin GM Tablet (15) side effects, there are can be others also. These have been listed below. Normally, these side effects of Orcerin GM Tablet (15) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Orcerin GM Tablet (15)'s effect is Unknown during pregnancy and Unknown for lactating mothers. Warnings related to Orcerin GM Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Orcerin GM Tablet (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Orcerin GM Tablet (15) in conditions like Kidney Disease. The section on Orcerin GM Tablet (15) contraindications lists all such conditions.
Drug reaction of Orcerin GM Tablet (15) with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Orcerin GM Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Orcerin GM Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Orcerin GM Tablet (15) is used -
Severe
Mild
Common
Is the use of Orcerin GM Tablet (15) safe for pregnant women?
Side effects of Orcerin GM during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Orcerin GM Tablet (15) safe during breastfeeding?
Information about safety of Orcerin GM for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Orcerin GM Tablet (15) on the Kidneys?
Information about safety of Orcerin GM for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Orcerin GM Tablet (15) on the Liver?
Information about safety of Orcerin GM for the liver is not available since scientific research on this is yet to be done.
What is the effect of Orcerin GM Tablet (15) on the Heart?
Side effects of Orcerin GM on heart are unknown because research on this has not been conducted yet.
Orcerin GM Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Orcerin GM Tablet (15) unless your doctor advises you to do so -
Is this Orcerin GM Tablet (15) habit forming or addictive?
Orcerin GM Tablet (15) is not addictive in nature.
Interaction between Food and Orcerin GM Tablet (15)
Due to a lack of research, nothing can be said about the consequences of taking Orcerin GM Tablet (15) together with food.
Interaction between Alcohol and Orcerin GM Tablet (15)
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Orcerin GM Tablet (15).
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1339-1340